3tl5: Difference between revisions
From Proteopedia
Jump to navigationJump to search
m Protected "3tl5" [edit=sysop:move=sysop] |
No edit summary |
||
| Line 1: | Line 1: | ||
'''Unreleased structure''' | '''Unreleased structure''' | ||
The entry 3tl5 is ON HOLD | The entry 3tl5 is ON HOLD until Paper Publication | ||
Authors: Murray, J.M., Wiesmann, C. | Authors: Murray, J.M., Wiesmann, C. | ||
Description: Discovery of GDC-0980: a Potent, Selective, and Orally Available Class I Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Kinase Inhibitor for the Treatment of Cancer | Description: Discovery of GDC-0980: a Potent, Selective, and Orally Available Class I Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Kinase Inhibitor for the Treatment of Cancer | ||
Revision as of 08:40, 30 October 2011
Unreleased structure
The entry 3tl5 is ON HOLD until Paper Publication
Authors: Murray, J.M., Wiesmann, C.
Description: Discovery of GDC-0980: a Potent, Selective, and Orally Available Class I Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Kinase Inhibitor for the Treatment of Cancer
